• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Intraosseous and intravenous vascular access are equally effective for ROSC following out-of-hospital cardiac arrest

byAnna YangandKiera Liblik
March 7, 2025
in Cardiology, Emergency, Surgery Classics, The 2MM Team, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized clinical trial, among patients who had an out-of-hospital cardiac arrest, no significant difference was found in sustained return of spontaneous circulation between intraosseous and intravenous vascular access.

2. Rates of survival and survival with a favorable neurologic outcome at 30 days were also similar between the two groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Out-of-hospital cardiac arrest is a common event that is associated with high mortality. Current international guidelines recommend the use of epinephrine, in some cases in combination with amiodarone or lidocaine, in these situations, and administration of these drugs requires the establishment of vascular access. Both intravenous and intraosseous vascular access are routinely attempted during out-of-hospital cardiac arrest for this purpose, but international guidelines recommend the use of intravenous access, albeit with a very low certainty of evidence. The present trial assessed the efficacy of intraosseous vascular access compared with intravenous vascular access for sustained return of spontaneous circulation during out-of-hospital cardiac arrest. Compared with intravenous vascular access, intraosseous vascular access resulted in similar incidences of sustained return of spontaneous circulation. Furthermore, there were no significant differences in survival at 30 days or survival at 30 days with a favorable neurologic outcome between the two groups. Limitations of the study included treating clinicians being aware of trial-group assignments and the study not being powered for analysis of more patient-centered long-term outcomes, which would require a larger sample size. Nevertheless, these findings provide valuable insight that the efficacy of drugs given during cardiac arrest does not depend significantly on the route of administration.

Click to read the study in NEJM

In-Depth [randomized controlled trial]: This randomized superiority trial assessed the efficacy of intraosseous vascular access compared with intravenous vascular access concerning the sustained return of spontaneous circulation during out-of-hospital cardiac arrest. Patients 18 years of age or older for whom vascular access was indicated during an out-of-hospital cardiac arrest, and who did not have a suspected traumatic cause of the cardiac arrest, were included. The primary outcome was a sustained return of spontaneous circulation, defined as a palpable pulse or other signs of circulation with no further use of chest compressions for at least 20 minutes. A total of 1,479 patients were included in the study, with 731 assigned to the intraosseous group and 748 assigned to the intravenous group. A sustained return of spontaneous circulation occurred in 30% of patients in the intraosseous group, compared with 29% of patients in the intravenous group (risk ratio, 1.06; 95% Confidence Interval [CI], 0.90 to 1.24; P=0.49). Additionally, at 30 days, 12% of patients in the intraosseous group were alive, compared with 10% of patients in the intravenous group (risk ratio, 1.16; 95% CI, 0.87 to 1.56) and 9% of patients in the intraosseous group had a favorable neurologic outcome compared with 8% in the intravenous group (risk ratio, 1.16; 95% CI, 0.83 to 1.62). With regard to safety, adverse events were uncommon and limited to extravasation, bradyarrhythmia, and ventricular tachyarrhythmia. In summary, among patients who had an out-of-hospital cardiac arrest, there was no significant difference in sustained return of spontaneous circulation, survival at 30 days, or survival at 30 days with a favorable neurologic outcome between patients who underwent intraosseous vascular access compared with intravenous vascular access.

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Computed tomography angiography of the head and neck may inform emergency management in patients with suspected stroke

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiac arrestcardiologyemergencyOHCAROSC
Previous Post

Intraosseous drug administration does not improve survival in out of hospital cardiac arrest

Next Post

Abelacimab reduces bleeding risk compared to rivaroxaban in atrial fibrillation

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Emergency

Computed tomography angiography of the head and neck may inform emergency management in patients with suspected stroke

March 9, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
Next Post
Image-guided percutaneous drainage of pericardial effusions is safe and effective

Abelacimab reduces bleeding risk compared to rivaroxaban in atrial fibrillation

Chemotherapy and stem-cell transplant for multiple myeloma remain superior

CAR+ T-cell lymphoma linked to cilta-cel therapy in myeloma

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind March 10, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Repetitive transcranial magnetic stimulation may reduce the incidence of chronic postsurgical pain after thoracoscopic surgery
  • Renal point-of-care ultrasound may be effective at identifying patients with nephrolithiasis
  • Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.